Table 5.
Airway Evaluation, Inclusion and Exclusion Criteria for Resectability Before or During Surgical Intervention
| Immediate Airway Evaluation |
| Does the patient have stridor? |
| Is immediate tracheostomy required? |
| Prerequisites/Inclusion Criteria for Surgery |
| Detailed surgical aerodigestive evaluation: |
| Fiberoptic evaluation including vocal cord status: laryngeal, subglottic, and upper tracheal regions need to be examined |
| Contrast-enhanced imaging of neck and upper mediastinum (CT or MRI preferred over ultrasound) |
| Consider: Endoscopic visualization of esophagus to assess invasion |
| Consider: Bronchoscopic visualization to assess tracheal invasion |
| Is R0/R1a resection expected? |
| R0/R1 resection anticipated without extensive visceral/vascular resection (laryngectomy, arterial/tracheal resection, permanent tracheostomy not anticipated) |
| Assembled surgical team optimally poised for the planned surgery |
| Undertake systematic evaluation (experienced surgeon, endocrinologist, pathologist, radiation oncology, medical oncology, radiology, nuclear medicine, and palliative care and ethics consultations) |
| • Assure correct pathologic diagnosis |
| FNA and core, negative calcitonin, expert pathology review including immunohistochemical marker assessment; send sample for genomic interrogation (especially BRAFV600E mutation assessment) |
| • Completed radiographic evaluation/clinical staging (Table 3): |
| Define global clinical stage (IVA, IVB, IVC) |
| Brain imaging (MR preferred, else contrast-enhanced CT) |
| • Patient comorbidities and psychosocial fitness for surgery assessed—and acceptable to proceed based upon global patient condition |
| • Patient competent in terms of decision-making capacity and meeting the U-ARE criteria and with sufficient understanding to make thoughtful decisions (see Table 4 and consider involvement of surrogate decision makers as needed) |
| • Patient goals of care, preferences, code (DNR/DNI) status, advanced directives, and surrogate/proxy decision makers defined |
| • Consensus achieved with patient and team on initial therapeutic plan and go/no-go for surgery |
| Exclusionary Conditions Before or at Time of ATC Surgery |
| Patient condition, goals of care, or decision-making capacity unsuitable for surgery |
| High-volume ATC metastasesb |
| Anticipated prohibitive morbidity from required surgical procedure? |
| Unacceptably high risk of extensive laryngeal, tracheal, bilateral nerve, esophageal, and/or vascular resection required to achieve R0/R1 resection |
| Anticipated time of postoperative recovery prohibitive in the context of anticipated need for additional superimposed therapies (e.g., chemoradiotherapy) |
R0, negative microscopic and gross margin resection; R1, negative gross margin resection.
High-volume metastatic disease should preclude surgery, but coexistent metastatic DTC or oligometastatic/low-volume metastatic ATC should not necessarily preclude surgery.
DNI, do not intubate; DNR, do not resuscitate; FNA, fine needle aspiration.